Authors: Bruskewitz, RC

Citation: Rc. Bruskewitz, Transurethral prostatic resection or laser therapy for men with acute urinary retention: The CLasP randomized trial - Comment, J UROL, 166(1), 2001, pp. 170-171

Authors: Rhodes, PR Krogh, RH Bruskewitz, RC

Citation: Pr. Rhodes et al., Impact of drug therapy on benign prostatic hyperplasia-specific quality oflife, UROLOGY, 53(6), 1999, pp. 1090-1098

Authors: Hudson, PB Boake, R Trachtenberg, J Romas, NA Rosenblatt, S Narayan, P Geller, J Lieber, MM Elhilali, M Norman, R Patterson, L Perreault, JP Malek, GH Bruskewitz, RC Roy, JB Ko, A Jacobsen, CA Stoner, E

Citation: Pb. Hudson et al., Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years, UROLOGY, 53(4), 1999, pp. 690-695

Authors: Klein, BEK Klein, R Lee, KE Bruskewitz, RC

Citation: Bek. Klein et al., Correlates of urinary symptom scores in men, AM J PUB HE, 89(11), 1999, pp. 1745-1748

Authors: Roehrborn, CG Burkhard, FC Bruskewitz, RC Issa, MM Perez-Marrero, R Naslund, MJ Shumaker, BP

Citation: Cg. Roehrborn et al., The effects of transurethral needle ablation and resection of the prostateon pressure flow urodynamic parameters: Analysis of the United States randomized study, J UROL, 162(1), 1999, pp. 92-97

Authors: Flanigan, RC Reda, DJ Wasson, JH Anderson, RJ Abdellatif, M Bruskewitz, RC

Citation: Rc. Flanigan et al., 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: A Department of Veterans Affairs Cooperative Study - Reply, J UROL, 161(2), 1999, pp. 614-614